Delta 9 Cannabis Inc (CVE:NINE – Get Free Report) rose 3% on Thursday . The company traded as high as C$1.13 and last traded at C$1.03. Approximately 68,728 shares changed hands during mid-day trading, a decline of 41% from the average daily volume of 117,300 shares. The stock had previously closed at C$1.00.
Delta 9 Cannabis Stock Performance
The stock has a market cap of C$89.36 million and a P/E ratio of 19.07. The company has a quick ratio of 2.04, a current ratio of 4.44 and a debt-to-equity ratio of 33.00. The business has a 50 day moving average price of C$1.03 and a two-hundred day moving average price of C$1.03.
Delta 9 Cannabis Company Profile
Delta 9 Cannabis Inc operates as an integrated cannabis company. The company, through its subsidiary, Delta 9 Bio-Tech Inc, engages in the production of medical marijuana. It primarily provides cannabis strains, as well as start-up materials and support services, including genetics (plants), grow pods, and consulting services to new and existing licensed producers.
Further Reading
- Five stocks we like better than Delta 9 Cannabis
- How to Invest in the FAANG Stocks
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- About the Markup Calculator
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- Stock Sentiment Analysis: How it Works
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Receive News & Ratings for Delta 9 Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Delta 9 Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.
